From May 8, 2023 to June 30, 2023, the company has repurchased 192,400 shares, representing 0.42% for ¥556.87 million. With this, the company has completed the repurchase of 192,400 shares, representing 0.42% for ¥556.87 million under the buyback announced on May 8, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,185 JPY | -1.09% | -12.86% | +3.07% |
08/05 | Japanese Shares Swing to Red Amid Profit-Taking, US Rate Cut Uncertainty | MT |
08/05 | Kissei Pharmaceutical's Attributable Profit Jumps 6% in Fiscal 2023; Shares Tumble 11% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.07% | 903M | |
+7.91% | 72.81B | |
+12.64% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
-26.13% | 2.32B | |
+19.31% | 2.17B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- 4547 Stock
- News Kissei Pharmaceutical Co., Ltd.
- Tranche Update on Kissei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 8, 2023.